Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3664231 | 0.90 | PTGDR (0.54) | PTGIRPTGDR | |
| Bicarbonate SCHEMBL16857989 | 0.90 | PTGIR (0.56) | PTGIRPTGDR | |
| SCHEMBL2119735 | 0.84 | PTGDR (0.61) | PTGIRPTGDR | |
| SCHEMBL2118072 | 0.82 | PTGDR (0.53) | PTGIRPTGDR | |
| Bicarbonate SCHEMBL16857990 | 0.80 | PTGDR (0.56) | PTGIRPTGDR | |
| Bicarbonate SCHEMBL14344089 | 0.79 | PTGIR (0.67) | PTGIRPTGDR | |
| Bicarbonate SCHEMBL16857988 | 0.76 | PTGDR (0.60) | PTGIRPTGDR | |
| SCHEMBL2118071 | 0.76 | PTGDR (0.72) | PTGIRPTGDR | |
| SCHEMBL2121180 | 0.76 | PTGIR (0.58) | PTGIRPTGDR | |
| SCHEMBL2117054 | 0.76 | PTGDR (0.56) | PTGIRPTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2177513-A1 | PHENYLACETIC ACID COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2010-04-21 | — | — | EP | claimed |
| EP-2177513-B1 | PHENYLACETIC ACID COMPOUND | ONO PHARMACEUTICAL CO (JP) | 2015-07-01 | — | — | EP | disclosed |
| US-8809524-B2 | Phenylacetic acid compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20130225808-A1 | PHENYLACETIC ACID COMPOUND | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-08-29 | — | — | US | disclosed |
| EP-2177513-A1 | PHENYLACETIC ACID COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2010-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225808-A1 | PHENYLACETIC ACID COMPOUND | PC, PAH, PDHA2 | PTGIR 3123/4885PTGDR 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.